A panel discussion on extended treatment intervals in retinal therapy breaks the mold at COPHy 2025

Panel discussions are par for the course at most major eye care meetings, but at the Congress on Controversies in Ophthalmology (COPHy), the format is something of an anomaly.

COPHy 2025 is underway in Seville, Spain. This year, the 16th annual congress will run from 4-5 April, and ahead of the meeting, the Ophthalmology Times Europe team spoke with the COPHy co-chairs for the March/April cover story.

In this clip, Anat Loewenstein, MD, head of the Department of Ophthalmology at the Tel Aviv Medical Center in Tel Aviv, Israel, discusses her role as a co-chair for the meeting. She highlighted the contributions of Patricia Udaondo, MD, PhD, FEBO, the local co-chair for this year's meeting. She also commended the local clinicians, especially those in the surgical retina space, who made the weekend possible.

Additionally, Prof Loewenstein discussed abundance of data and emerging treatments in the field of age-related macular degeneration (AMD) treatments. A major influx of data in the AMD and general retina space have made the topic more complicated than ever. As more drugs enter the market, Prof Loewenstein said, the continually-growing base of information complicates the binary approach to discussions and to doing what is right for the patient.